CADILAHC Intraday Analysis...

CADILAHC Share Price

Open 457.00 Change Price %
High 461.50 1 Day -1.20 -0.26
Low 450.95 1 Week 12.00 2.70
Close 455.70 1 Month 10.20 2.29
Volume 495836 1 Year 127.70 38.93
52 Week High 466.85
52 Week Low 305.00
CADILAHC Important Levels
Resistance 2 465.48
Resistance 1 461.45
Pivot 456.05
Support 1 449.95
Support 2 445.92
NSE INDIA Most Active Stocks
SUZLON 20.85 0.24%
GMRINFRA 17.15 -3.92%
JPASSOCIAT 13.10 0.77%
ADANIENT 118.55 -20.94%
IBREALEST 154.05 -2.59%
IDFCBANK 61.20 3.03%
SOUTHBANK 24.15 -3.21%
PNB 167.15 3.76%
UNITECH 5.70 -2.56%
JPINFRATEC 13.85 6.95%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
VSSL 124.80 20.00%
ATNINTER 0.30 20.00%
RKDL 13.65 19.74%
WELINV 127.75 18.29%
TCIDEVELOP 533.00 17.56%
HBSTOCK 25.65 16.06%
HUBTOWN 146.30 12.50%
SYNCOM 6.75 12.50%
NAKODA 0.45 12.50%
More..
NSE INDIA Top Losers Stocks
BLS 170.40 -89.85%
ADANIENT 118.55 -20.94%
SHILPI 165.90 -19.99%
AUSTRAL 0.25 -16.67%
MAHASTEEL 85.25 -9.74%
ZENSARTECH 838.65 -8.73%
KAMATHOTEL 45.05 -8.53%
ZENITHBIR 0.55 -8.33%
NICCO 0.55 -8.33%
ROLLT 9.75 -8.02%
More..

Cadila Healthcare Limited (NSE: CADILAHC)

CADILAHC Technical Analysis 5
As on 26th Apr 2017 CADILAHC Share Price closed @ 455.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 381.53 & Strong Buy for SHORT-TERM with Stoploss of 431.97 we also expect STOCK to react on Following IMPORTANT LEVELS.
CADILAHC Target for April
1st Target up-side 468.49
2nd Target up-side 487.05
3rd Target up-side 505.62
1st Target down-side 415.51
2nd Target down-side 396.95
3rd Target down-side 378.38
CADILAHC Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 58.55 Sideways
MFI (14) MFI is 64.79 Sideways
CCI (20) CCI is 96.51 Sideways
WILLIAM %R (14) William %R is -40.40 Sideways
ADX (14) ADX is 15.11 Range Bound
PSAR Stoploss For Long Buy 439.73
10 Day Avg Volume Traded -2.32 % Less then 10 Day Average Volume
CADILAHC Other Details
Segment EQ
Market Capital 40527183872.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.zyduscadila.com
CADILAHC Address
CADILAHC
Zydus Tower
Satellite Cross Roads
Ahmedabad, 380015
India
Phone: 91 79 2686 8100
Fax: 91 79 2686 2365
Interactive Technical Analysis Chart Cadila Healthcare Limited ( CADILAHC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cadila Healthcare Limited
CADILAHC Business Profile
Cadila Health is in the Pharmaceuticals sector. Cadila Laboratories was founded in 1952 by Ramanbhai Patel(1952–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Shri Indravadan Modi. The company evolved over the next four decades into one of India's established pharmaceutical companies. In 1995 the Patel and Modi families split, with the Modi family's share being moved into a new company called Cadila Pharmaceuticals Ltd. and Cadila Healthcare became the Patel family's holding company. Cadila Healthcare did its IPO on the Bombay Stock Exchange in 2000. Its stock code on the Bombay exchange is 532321. In 2001 the company acquired another Indian pharmaceutical company called German Remedies. On June 25, 2007, the company signed an agreement to acquire 100 per cent stake in Brazil's Quimica e Farmaceutica Nikkho do Brasil Ltda (Nikkho) for around 26 million dollars. In 2010, Cadila Pharmaceuticals received a prestigious Wellcome Trust Award under the new "R&D for Affordable Healthcare in India" initiative. The current market capitalisation stands at Rs 15,310.07 crore.The company has reported a consolidated sales of Rs 1746.79 crore and a Net Profit of Rs 191.57 crore for the quarter ended Sep 2013. The company management includes Pankaj R Patel - Chairman & Managing Director, Sharvil P Patel - Deputy Managing Director, Humayun Dhanrajgir - Director, Mukesh M Patel - Director, Nitin R Desai - Director, Apurva S Diwanji - Director. It is listed on the BSE with a BSE Code of 532321 and the NSE with an NSE Code of CADILAHC. Its Registered office is at "Zydus Tower", Satellite Cross Roads,,Sarkhej Gandhinagar Highway Ahmedabad,Gujarat - 380015.